Author

G. Inman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Mukundan· 2 shared A. P. Hinck· 2 shared C. S. Hinck· 2 shared C. Schoenherr· 2 shared M. P. J. White· 2 shared P. ten Dijke· 2 shared R. M. Maizels· 2 shared A. Sanders· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. Mukundan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts

S. E. White, T. A. Schwartze, A. Mukundan, C. Schoenherr, S. P. Singh, M. van Dinther, K. T. Cunningham, M. P. J. White, T. Campion, J. Pritchard, C. S. Hinck, P. ten Dijke, G. Inman, R. M. Maizels, A. P. Hinck

This paper shows TGM6, a helminth protein, mimics TGF-β binding to TβRII to inhibit TGF-β signaling in fibroblasts but not T cells.

bioRxiv · Dec 22, 2023 · PreprintBiochemistry

The helminth TGF-beta mimic TGM4 is a modular ligand that binds CD44, CD49d and TGF-beta receptors to preferentially target myeloid cells

S. Singh, D. J. Smyth, K. Cunningham, A. Mukundan, C.-H. Byron, C. S. Hinck, M. P. J. White, C. Ciancia, N. Wosowska, A. Sanders, R. Jin, S. Lilla, S. Zanivan, C. Schoenherr, G. Inman, , R. M. Maizels

This paper identifies TGM4, a helminth TGF-beta mimic, as a modular ligand that selectively targets myeloid cells through specific receptor interactions, differing from TGM1's broader T cell targeting.

bioRxiv · Nov 13, 2023 · PreprintImmunology